Superiority of MACI® Versus Microfracture Treatment in Patients With Symptomatic Articular Cartilage Defects in the Knee

NCT00719576 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Articular Cartilage Defect

Interventions

BIOLOGICAL: autologous cultured chondrocytes on porcine collagen membrane
PROCEDURE: Microfracture

Sponsor

Vericel Corporation